Login / Signup

Impact of induction immunosuppression on patient survival in heart transplant recipients treated with tacrolimus and mycophenolic acid in the current allocation era.

Alpesh A AminFaris G ArajVenkatesh K AriyamuthuMark H DraznerMehmet U S AyvaciPradeep P A MammenMutlu MeteMarcus A UreyBekir Tanriover
Published in: Clinical transplantation (2019)
In this contemporary cohort of heart transplant recipients receiving TAC/MPA, neither r-ATG nor IL2-RA were associated with a survival benefit. On the contrary, adjusted analyses showed a significantly higher mortality in the r-ATG group and a trend toward higher mortality in the IL2-RA group. While caution is needed in interpreting treatment effects in an observational cohort, these data call into question the benefit of induction therapy as a common practice and highlight the need for more studies.
Keyphrases